{"time_collected":"2023-03-08 12:32:28.396530-05:00","top_headers":[{"heading":"*Shrooms Talks* [March 08, 2023] Daily Discussion Thread","time_posted":"6 hours ago"},{"heading":"Cybin to Participate in the Oppenheimer 33rd Annual Healthcare Conference","time_posted":"5 hours ago"},{"heading":"Cory Booker And Rand Paul File Revised Bill To Reschedule Psychedelic Breakthrough Therapies","time_posted":"14 hours ago"},{"heading":"The Importance of Cybin’s Next-Generation Psilocybin","time_posted":"14 hours ago"},{"heading":"A non-hallucinogenic LSD analog with therapeutic potential for mood disorders","time_posted":"17 hours ago"},{"heading":"Todd Shapiro on a \"Exotic\" Expansion in the Mushroom Business | The CSE Podcast S3-Ep8","time_posted":"21 hours ago"},{"heading":"Not a great look for ATMA Journey Centers… (and by proxy MCUR). It will be interesting to see how this plays out.","time_posted":"13 hours ago"},{"heading":"Bionomics (ASX:BNO) Trading Halt (at request of the company pending trial results)","time_posted":"15 hours ago"},{"heading":"*Shrooms Talks* [March 07, 2023] Daily Discussion Thread","time_posted":"1 day ago"},{"heading":"Atai cuts workforce 30%","time_posted":"2 days ago"},{"heading":"atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates | ATAI Life Sciences N.V.","time_posted":"2 days ago"},{"heading":"Synthesis Institute’s Psychedelic Training Program Unreachable by Students","time_posted":"2 days ago"},{"heading":"What if Every Business Owner in America Did Psychedelic Assisted Therapy?","time_posted":"2 days ago"},{"heading":"Testing psilocybin potency: 5 Questions for laboratory chemist Bjorn Fritzsche | The Microdose","time_posted":"2 days ago"},{"heading":"3 misperceptions about legal psilocybin in Oregon","time_posted":"2 days ago"},{"heading":"Mindset Pharma and Pharmla Complete First Sale of Pharmaceutical Grade Psilocybin into the Australian Market","time_posted":"2 days ago"},{"heading":"ATAI Company Presentation March 2023","time_posted":"2 days ago"},{"heading":"Psychedelic Bulletin #132: COMPASS Pathways Amends Phase 3 Program; Stamets Stack Finally Patented; Learning from Zuranolone?","time_posted":"2 days ago"}],"rules":["Be respectful and kind.","Titles must be descriptive. Use article's actual title in post wherever possible. No click-bait.","Posts must have a clear connection to the legal psychedelics industry.","No low-effort comments or r/wallstreetbets behaviour. This forum is for discussion and analysis. (+)","Memes are allowed but subject to removal (+)","Do not post screenshots of your investment returns.","No solicitation. (+)","News/Media organizations wishing to post regular content must adhere to the official guidelines. (+)","Corporations wishing to request an AMA must refer to the official guidelines. (+)"],"subreddits":{},"about":{"header":"About Community","description":"A community of investors in the legal psychedelics industry. Global drug policy is changing, and psychedelic therapies are next in line for decriminalization, research, and sale. Please subscribe and contribute anything that relates to the legal industry of psychedelics. For live discussion, visit our Discord server: https://discord.gg/Pq8VDfs.","created":"Created Nov 12, 2017","stats":["58.1k Members","211 Online"]},"other_information":[{"header":"Discord Channel","description":"Join us in our Discord server for live discussion."},{"header":"Official AMA Schedule","description":"Upcoming AMAs\nHave a suggestion or want us to host an AMA with your psychedelics company? Let us know via modmail.\nRecent AMAs\nRonan Levy from Field Trip Health -- 11/22/2022\nBill Ciprick and Dane Stevens from Optimi Health -- 05/10/2022\nDr. Lyle Oberg from MYND Life Sciences -- 02/01/2022\nJosh Hardman from Psilocybin Alpha -- 01/04/2022\nGreg Mckee from Tryp Therapeutics -- 12/13/2021\nFlorian Brand and Srinivas Rao from ATAI Life Sciences -- 11/23/2021\nJames Lanthier from Mindset Pharma -- 11/02/2021\nKelsey Ramsden from Mind Cure Health -- 10/12/2021\nRonan Levy from Field Trip Health -- 09/21/2021\nDaniel Carcillo and Mike Tyson from Wesana Health -- 08/10/2021\nTim Moore from Havn Life Sciences -- 07/18/2021\nRami Mustafa from The Conscious Fund -- 06/29/2021\nDoug Drysdale from Cybin Inc. -- 06/08/2021\nDr. Malcolm Barratt-Johnson from Albert Labs -- 05/18/2021\nDr. Joseph Tucker from MagicMed Industries -- 04/27/2021\nJeff Stevens from Psyched Wellness -- 04/06/2021\nFabio Chianelli from PharmaTher Inc. -- 03/16/2021\nRob Tessarolo and Trevor Millar from NeonMind Biosciences -- 02/23/2021\nRonan Levy from Field Trip Health -- 01/18/2021\nPayton Nyquvest & Dr. Evan Wood from Numinus Wellness Inc. -- 12/16/2020"},{"header":"Community Resources","description":"Top Contributions\nAll the recent psychedelic research I could find with highlights. Arm yourselves with knowledge\nSubmitted by: u/AeonDisc Date: July 13th, 2021\nPSA on Shroom Stocks: Brokerages, US tickers list, OTC, bid-ask spread, limit orders, transaction fees, wash-sale rules\nSubmitted by: u/AeonDisc Date: May 15th, 2021\nSo you want to get into Psychedelics - The Three Axes of Psychedelic Investing\nSubmitted by: u/I_Swim_I Date: February 14, 2021"},{"header":"Mush Rush Game","description":"Mush Rush is now available everywhere for Android and iOS! Download the game today from your device's app store. The game is free to play and built specifically for this community.\nAndroid (Google Play)\niOS (App Store)\nVisit our dedicated subreddit r/MushRushGame to leave questions, bug reports, feedback, and suggestions!"}]}